Infection of the bovine endometrium with Gram-negative bacteria commonly causes uterine disease. Toll-like receptor 4 (TLR4) on cells of the immune system bind Gram-negative bacterial lipopolysaccharide (LPS), stimulating the secretion of the proinflammatory cytokines interleukin 1B (IL1B) and IL6, and the chemokine IL8. Because the endometrium is the first barrier to infection of the uterus, the signaling cascade triggered by LPS and the subsequent expression of inflammatory mediators were investigated in endometrial epithelial and stromal cells, and the key pathways identified using short interfering RNA (siRNA) and biochemical inhibitors. Treatment of endometrial cells with ultrapure LPS stimulated an inflammatory response characterized by increased IL1B, IL6, and IL8 mRNA expression, and IL6 protein accumulation in epithelial cells, and by increased IL1B and IL8 mRNA expression, and IL6 and IL8 protein accumulation in stromal cells. Treatment of endometrial cells with LPS also induced the degradation of IKB and the nuclear translocation of NFKB, as well as rapid phosphorylation of mitogen-activated protein kinase 3/1 (MAPK3/1) and MAPK14. Knockdown of TLR4 or its signaling adaptor molecule, myeloid differentiation factor 88 (MYD88), using siRNA reduced the inflammatory response to LPS in epithelial and stromal cells. Biochemical inhibition of MAPK3/1, but not JNK or MAPK14, reduced LPS-induced IL1B, IL6, and IL8 expression in endometrial cells. In conclusion, epithelial and stromal cells have an intrinsic role in innate immune surveillance in the endometrium, and in the case of LPS this recognition occurs via TLR4-and MYD88-dependent cell signaling pathways.
INTRODUCTION
The endometrium is the mucosa lining the uterus, with roles in normal reproductive cycles, implantation, placentation, and pregnancy [1, 2] . Bos taurus commonly acquire ascending bacterial infections of the female genital tract after parturition, which leads to disease and infertility [3] . Indeed, contamination of the uterine lumen with bacteria occurs in ;90% of dairy cattle after parturition [4, 5] . These infections often lead to uterine disease, with ;40% of animals developing metritis within a week of parturition, persisting as endometritis for several weeks in ;20% of animals [3] . This uterine disease causes pain, malaise, and even mortality in the acute phase, and leads to infertility during the chronic phase. Based on detailed financial calculations by Sheldon et al. [3] and Drillich et al. [6] , the cost of uterine disease and the associated infertility was estimated to be $650 million per annum in the United States.
Infection of the endometrium with Gram-negative Escherichia coli is the first step in the pathogenesis of postpartum uterine disease in cattle [5, 7] . Infection with E. coli is associated with the presence of lipopolysaccharide (LPS; endotoxin) in the uterus, the acute-phase protein response, the severity of disease, and the extent of the infertility caused by uterine disease [5, 7, 8] . These infections also increase expression of mRNA transcripts in the endometrium that encode molecules associated with inflammation, such as the cytokines interleukin 1B (IL1B) and IL6, and the chemokine IL8 [9, 10] . The chemokine IL8 is responsible for attracting neutrophils and macrophages to the uterus [11] , whereas IL1B and IL6 are classical proinflammatory cytokines [12] .
Detection of bacteria in mammals depends on the recognition of their pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors on the cells of the innate immune system. The predominant family of pattern recognition receptors is that comprising the 10 Toll-like receptors (TLR1 to TLR10) [12] . Binding of microbial PAMPs to host cell TLRs leads to an inflammatory response, including the secretion of cytokines and chemokines. When mRNA levels of each of the 10 TLRs were examined in postpartum endometrium, it was only the expression of TLR4 that increased in animals with uterine disease [10] , and TLR4 is the specific pattern recognition receptor for LPS [12, 13] . The binding of LPS to TLR4 in complex with CD14 and LY96 (Lymphocyte antigen-96; also known as MD-2) initiates TIR (Toll/IL1 Receptor) domain intracellular signaling through adaptor molecules, predominantly myeloid differentiation factor 88 (MYD88) [14] . This TLR4 and MYD88 signaling results in the activation of downstream kinases, leading to the degradation of IKB, which frees NFKB to translocate to the nucleus, where it binds jB sites in the promoter region of genes encoding proinflammatory cytokines, including IL1B and IL6 [15] . In addition, MYD88 signaling activates the mitogenactivated protein kinase (MAPK) cascade [16] . Activated members of the MAPK family, including MAPK3/1 (also known as ERK1/2), MEK, and MAPK14 (also known as p38), play a role in gene transcription and, in the case of MEK and MAPK14 in IL6 mRNA stability [17] [18] [19] . Furthermore, the NFKB and MAPK pathways synergize through synchronized binding to jB and AP-1 sites found together in the promoters of numerous genes, including IL8, that are up-regulated in response to TLR ligand binding [20] .
Epithelial cells form the first cellular barrier to infection in the intact endometrium, but after parturition the epithelium is disrupted, and so the stromal cell compartment is also exposed to the ascending microbes [3, 9] . Bovine endometrial cells express TLR4, LY96, and CD14, and treatment with LPS was associated with a switch in prostaglandin secretion from the F to E series by epithelial cells [21] . However, the absolute requirement for TLR4 or MYD88 for innate immunity has not been tested in bovine endometrial cells, and there are tissueand species-specific differences in TLR signaling or function between domestic animals and humans or rodents [22] . Furthermore, the intracellular signaling mechanisms associated with LPS-stimulated inflammation are not known for the endometrium, and this is important if tissue-specific, targeted therapeutics are to be designed to limit the impact of uterine disease in cattle.
So, the present study tested the hypothesis that TLR4-and MYD88-dependent signaling is essential for the response to LPS by the epithelial and stromal cells of the bovine endometrium. Furthermore, the signaling cascade triggered by the engagement of LPS with TLR4 and the subsequent expression of inflammatory mediators by primary endometrial cells were explored using biochemical inhibitors and short interfering RNA (siRNA). Although epithelial cells are important because they form a barrier to infection in the intact endometrium, the present study also focused on endometrial stromal cells for three reasons. First, the epithelial cells are disrupted and/or sloughed during parturition and the postpartum period to expose the stroma to PAMPs [9, 23] . Second, stromal cells are far more abundant than epithelial cells [9, 23, 24] . Finally, the stromal cells are adjacent to the vasculature, so their elaboration of cytokines and chemokines may have more impact than inflammatory mediators from epithelial cells [9, 23] .
MATERIALS AND METHODS

Endometrial Cell Culture
All procedures were carried out in compliance with the Animals (Scientific Procedures) Act 1986, and experimental protocols were approved by the local ethics review committee. Bovine uteri were collected at a local abattoir from postpubertal nonpregnant animals with no evidence of genital disease or microbial infection, and the uteri were kept on ice until further processing in the laboratory. Postpartum cattle were not used because experiments would be confounded by ubiquitous bacterial contamination of the uterus [3] , existing endometrial inflammation [25] , disruption of the epithelium [9, 23] , and the presence of damage-associated molecular patterns [26] . The stage of the reproductive cycle was determined by observation of ovarian morphology as previously described [24] . Genital tracts were selected for endometrial culture from animals on Days 1-4 of the estrous cycle with an ovarian stage I corpus luteum containing a recently ruptured follicle because in these animals, similar to postpartum cows, peripheral plasma progesterone concentrations are basal [24] . A total of 80 animals were used during the studies. The endometrium from the horn ipsilateral to the corpus luteum was dissected as previously described [21] . Briefly, tissue was digested in 25-ml sterile digestive solution, made with 375 N-benzoyl-L-arginine ethyl ester (BAEE) units of Trypsin ethylene diamine tetraacetic acid (Sigma, Poole, U.K.), 50 mg of collagenase II (Sigma), 100 mg of bovine serum albumin (BSA; Sigma), and 10 mg of DNase I (Sigma) in 100 ml of Hanks balanced salt solution. Following a 1-h incubation in a shaking water bath at 378C, the cell suspension was filtered through a 40-lm mesh (Fisher Scientific, Loughborough, U.K.) to remove undigested material, and the filtrate was resuspended in washing medium comprising HBSS with 10% fetal bovine serum (FBS; Sigma). The suspension was centrifuged at 100 3 g for 10 min, and following two further washes in washing medium, the cells were resuspended in RPMI-1640 medium containing 10% FBS, 50 IU/ml penicillin, 50 lg/ml streptomycin, and 2.5 lg/ml amphotericin B. The cells were plated at a density of 1 3 10 5 cells per milliliter in 6-, 12-, or 24-well plates (Helena Bioscience, Gateshead, U.K.). To obtain separate stromal and epithelial cell populations, the cell suspension was removed 18 h after plating, which allowed selective attachment of stromal cells [27] . The removed cell suspension was then replated and incubated, allowing epithelial cells to adhere. Stromal and epithelial cell populations were determined to be .99% pure, as we have previously described [21, 25] . The culture media were changed every 48 h until the cells reached approximately 90% confluence. Cell cultures were maintained at 378C, 5% CO 2 , in a humidified incubator and were used within 10 days.
Endometrial Cell Culture Treatments
Endometrial stromal and epithelial cells (99% confluent) were challenged with 1 lg/ml ultrapure LPS from E. coli 0111:B4 (InvivoGen, Toulouse, France) for 6 h to evaluate cellular mRNA expression; for 6, 24, or 48 h to measure the accumulation of inflammatory mediators in cell supernatants; or for 5-60 min to monitor intracellular signaling molecules, as indicated in Results. The LPS concentration was previously validated using endometrial cells [25] and reflected the concentrations in the uterine lumen of infected animals [5, 7] . Each experiment was performed using cells isolated from at least three independent animals, and each treatment was replicated at least twice. Supernatants were collected and stored at À208C until analyzed, and cells were processed for quantitative PCR (qPCR) or immunoblotting.
Quantitative PCR
After treatment, cells were washed with 1 ml of PBS, and the RNA was subsequently extracted using the RNeasy Mini Kit and automated Qiacube system (Qiagen, Crawley, U.K.). The extracted RNA was quantified using a Nanodrop ND1000 spectrophotometer (Labtech, Ringmer, U.K.). For cDNA synthesis, 1 lg of total RNA was added to a genomic DNA elimination reaction, followed by conversion to cDNA (Quantitect Reverse Transcription Kit; Qiagen), according to the manufacturer's instructions. Then, qPCR was performed to analyze gene expression using intron-spanning gene-specific primers (Supplemental Table S1 ; all Supplemental Data are available online at www.biolreprod.org) and the IQ5 system (Bio-Rad, Hemel Hempstead, U.K.). The starting quantity of mRNA from experimental samples was determined using standard curves generated from reference RNA with Quantifast SYBR green (Qiagen). The mRNA expression levels were then normalized to ACTB. The PCR analyses were conducted in triplicate. 
ELISA
Immunoblotting
Proteins were normalized to 1 lg/ll using the DC Assay (Bio-Rad) and separated (10 lg per lane) using 10% (vol/vol) SDS-PAGE. Prestained molecular weight markers were run in parallel lanes (Bio-Rad). After electrophoresis, proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad); nonspecific sites were blocked using a solution of 5% (wt/vol) BSA (Sigma) in Tris-buffered saline (TBS) overnight at 48C with gentle agitation. Membranes were probed with antibodies targeting phosphorylated MAPK3/1 (M8159; Sigma) and phosphorylated MAPK14 (Everest Biotech Ltd., Upper Heyford, U.K.). The antibody used was selected based on recognition of immunoreactive proteins of appropriate molecular weight. Primary antibodies were used at 1:1000 dilutions in 5% (wt/vol) BSA in TBS for 2 h with gentle agitation. After incubation, membranes were washed for 5 3 5 min in TBS and 0.1% Tween 20 (pH 7.6). Membranes were then incubated in secondary horseradish peroxidase-conjugated antibody (Cell Signaling Technology, Danvers, MA) in 5% (wt/vol) BSA in TBS for 1.5 h and washed for 5 3 5 min in TBS and 0.1% Tween 20 (pH 7.6). Steady-state levels of CRONIN ET AL.
immunoreactive proteins were visualized using enhanced chemiluminescence (Western C; Bio-Rad). Protein loading was evaluated and normalized by examining b-actin or a-tubulin protein levels using a b-actin antibody (Abcam, Cambridge, U.K.) or a-tubulin antibody (Invitrogen, Paisley, U.K.), respectively. The average peak densities of unsaturated bands were analyzed using Quantity-one software (Bio-Rad). Phosphorylated MAPK14 bands were normalized against total MAPK14 bands and phosphorylated MAPK3/1 bands normalized against total MAPK3/1 to adjust for loading and the data presented relative to untreated control.
Short Interfering RNA
Primary endometrial epithelial and stromal cells were transfected with Lipofectamine RNAiMAX Reagent (Invitrogen) and siRNA (designed using Dharmacon siDESIGN Center; Thermo Scientific) targeting TLR4 and MyD88 (duplex sequences in Supplemental Table S2 ). Briefly, RNAiMAX-RNAi duplex complexes were formed by adding 50 pmol of siRNA to 500 ll of Opti-MEM I Reduced Serum Media (without antibiotics; Invitrogen) in each well of a six-well plate (Helena Bioscience). For controls, 50 pmol of ONTARGETplus Non-targeting siRNA #1 (Dharmacon) was used instead of the targeted siRNA. Then, 7.5 ll of RNAiMAX was added to each well containing the diluted RNAi molecules and left for 20 min at room temperature. Exponentially growing cells were then seeded in 2.5 ml of complete RPMI growth media (without antibiotics) per well (7 3 10 5 epithelial cells, 5 3 10 5 stromal cells) to give approximately 50% confluency. All transfections were carried out in triplicate. LPS treatments were carried out within 24 h of the addition of the siRNA for the assessment of changes in mRNA, and 48 h for the assessment of changes in protein in the presence of RPMI-1640 medium containing 10% FBS.
Biochemical Inhibitors
Primary endometrial cells were exposed to each inhibitor at 378C for 30 min prior to and during treatment with 1 lg/ml LPS treatment for 6 h to evaluate mRNA expression, 6 or 24 h to measure the accumulation of inflammatory mediators, or 15 and 30 min for immunoblotting. Biochemical inhibitors were all purchased from Merck Chemicals (Nottingham, U.K.), with working concentrations determined during preliminary experiments. The MAPK3/1 activation inhibitor peptide I (used at a final concentration of 10 lM) is a cellpermeable peptide corresponding to the N-terminus of MEK1, and so acts as a specific inhibitor of MAPK3/1 activation. The inhibitor of MAPK3/1, U0126 (10 lM), functions by inhibiting the kinase activity of the upstream MAPK3/1 kinases, MEK1/MEK2 [29] . The inhibitor PD98059 (10 lM) has been shown to be a selective inhibitor of MEK1 and the MAPK cascade [30] . The inhibitor BAY 11-7082 (4 lM) inhibits phosphorylation of IKBA, resulting in a decreased activation of NFKB, and SB 203580 (10 lM) is a potent inhibitor of MAPK14. Controls for each experiment included equivalent volumes of media and vehicle, and media plus inhibitor. Cell survival was evaluated at 6 and 24 h by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay [31] .
Plasmids
The pIjBa-EGFP (Clontech, Saint-Germain-en-Laye, France) contains a fusion of IKBA to EGFP under the control of the hCMV-IE promoter. The p65-dsRed was produced by inserting a 1.6-kb p65 HindIII-BamHI fragment from p65-EGFP into the respective sites in the multiple cloning site of pdsRed1-N1 (Clontech), producing an in-frame C-terminal fusion of p65 to dsRed under the control of the hCMV-IE promoter [32] . These plasmids do not affect the fundamental characteristics of the NFKB signaling system, although rates of degradation of IKBA (loss of EGFP from cytoplasm) and nuclear translocation of NFKB (movement of dsRed from cytoplasm to nucleus) may differ [32, 33] (both plasmids were a kind gift from Dr. Violaine See, University of Liverpool, Liverpool, U.K.).
Cell Transfection
Initially, 2 3 10 5 stromal cells per chamber were resuspended in 500 ll of RPMI media (10% serum; antibiotic free) and incubated overnight at 378C in Lab-Tek 2-chambered coverglass slides (Nunc, Langenselbold, Germany). The following day, 1 lg of plasmid DNA was diluted in 50 ll of OPTI-MEM I Reduced Serum Medium (Invitrogen) and gently mixed by inversion. Then, 2 ll of Lipofectamine 2000 was diluted in 50 ll of OPTI-MEM I Reduced Serum Medium. After 5 min of incubation, the plasmid DNA and the Lipofectamine 2000 were combined and incubated for a further 20 min at room temperature. The complexes were then added to the cells and mixed gently by brief rocking.
After 6 h of incubation at 378C, the cells were washed in 13 PBS, and fresh serum-free RPMI was added, followed by incubation overnight at 378C.
Confocal Microscopy
Multiple-field time-lapse images of cells were captured every 5 min with an inverted confocal laser scanning microscope 710 (LSM; Carl Zeiss, Jena, Germany) using a 403 LD objective, an automated stage, and lasers at 488 and 543 nm. For each experiment, time-lapse images of four fields of untreated cells and four fields of cells treated with 1 lg/ml LPS were collected over a 100-min period.
Statistical Analysis
Endometrial cells were isolated independently; each experiment used between three and eight animals on separate occasions (as enumerated below), with animal designated as the statistical unit. The experiments used technical replicates of at least two wells of endometrial cells for each treatment. Data are FIG. 1. siRNA targeting TLR4 mRNA inhibits LPS-induced gene expression of inflammatory mediators in endometrial cells. Epithelial (A-D) and stromal (E-H) cells isolated from bovine endometrium were cultured for 6 h in medium (control, C) or media containing 1 lg/ml LPS purified from E. coli 0111:B4. In each independent set of experiments, cells received vehicle alone, vehicle plus siRNA targeting TLR4 (siTLR4; 50 pmol), or vehicle plus scrambled siRNA control (S; 50 pmol) 18 h before LPS treatment. Total RNA was extracted, and the mRNA levels of TLR4 (A and E), IL1B (B and F), IL6 (C and G), and IL8 (D and H) were assessed by qPCR (normalized to ACTB). Data are presented as mean þ SEM and represent at least three independent experiments. The significance was evaluated by ANOVA with Dunnett postcomparison test comparing vehicle and siRNA for cells treated with control media (A and E) or media containing LPS (A-H). *P , 0.05, **P , 0.01, ***P , 0.001.
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presented as mean þ SEM, and the significance of differences between groups was evaluated by one-way ANOVA with Dunnett postcomparison test, or by Kruskal-Wallis for comparison of inflammatory mediator mRNA expression between control and LPS treatments, using SPSS 16.0 (SPSS Inc., Chicago, IL) P values of ,0.05 were designated as significant.
RESULTS
Endometrial Cell Inflammatory Response to LPS
Preliminary time course experiments showed that in primary epithelial and stromal cells, the optimum time to evaluate LPSinduced changes in cytokine and chemokine mRNA levels was 6 h. There were significant increases in the expression of mRNA encoding IL1B, IL6, and IL8 associated with LPS treatment (mRNA fold changes of 110 6 52, 17 6 13, and 9.5 6 0.6, respectively, for epithelial cells, and mRNA fold changes of 103 6 79, 29 6 23, and 87 6 68, respectively, for stromal cells compared with untreated controls; P , 0.05 Kruskal-Wallis). There was also more IL6 protein in the supernatants of stromal cells treated with LPS for 6 h compared with controls (2188 6 908 vs. 152 6 115 pg/ml; P , 0.001). Following treatment with LPS for 24 h, the supernatants of epithelial cells had accumulated more IL6 than controls (149 6 29 vs. 94 6 31 pg/ml; P , 0.001), and stromal cell supernatants had accumulated more IL6 and IL8 than controls (1180 6 106 vs. 228 6 107 pg/ml IL6, P , 0.001; and 58 6 20 vs. 22 6 6 pg/ml IL8, P , 0.001). Although IL1B mRNA increased in both epithelial and stromal cells, mature IL1B protein could not be detected at 6 or 24 h after treatment with LPS in cell culture supernatants using ELISA. Furthermore, TNF could not be detected in culture supernatants from either cell type at 6 or 24 h after treatment with LPS.
TLR4 and MYD88 siRNA
Targeting TLR4 mRNA with siRNA reduced TLR4 mRNA expression in epithelial and stromal cells (Fig. 1, A and E,  respectively) . The treatment of epithelial or stromal cells with LPS had no effect on TLR4 mRNA expression or the efficacy of RNA interference (Fig. 1, A and E) . However, transfection with TLR4 siRNA reduced the fold induction of IL1B, IL6, and IL8 mRNA expression associated with 1 lg/ml LPS treatment in epithelial cells (Fig. 1, B-D) and in stromal cells (Fig. 1, F-H) .
Targeting MYD88 mRNA with siRNA reduced MYD88 mRNA expression in epithelial and stromal cells (Fig. 2, A and E, respectively). The treatment of epithelial or stromal cells with LPS had no effect on MYD88 mRNA expression or the efficacy of RNA interference (Fig. 2, A and E) . However, transfection with MYD88 siRNA reduced the fold induction of IL1B, IL6, and IL8 mRNA expression associated with LPS
FIG. 2. siRNA targeting MYD88 mRNA inhibits LPS-induced gene expression of inflammatory mediators in endometrial cells. Epithelial (A-
) and stromal (E-H) cells isolated from bovine endometrium were cultured for 6 h in medium (control, C) or media containing 1 lg/ml LPS purified from E. coli 0111:B4. In each independent set of experiments, cells received vehicle alone, vehicle plus siRNA targeting MYD88 (siMyD88; 50 pmol), or vehicle plus scrambled siRNA control (S; 50 pmol) 18 h before LPS treatment. Total RNA was extracted, and the mRNA levels of MYD88 (A and E), IL1B (B and F), IL6 (C and G), and IL8 (D and H) were assessed by qPCR (normalized to ACTB). Data are presented as mean þ SEM for fold changes relative to LPS and represent at least three independent experiments. The significance was evaluated by ANOVA with Dunnett postcomparison test comparing vehicle and siRNA for cells treated with control media (A and E) or media containing LPS (A-H). *P , 0.05, **P , 0.01, ***P , 0.001. 
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treatment in epithelial cells (Fig. 2, B-D) . In stromal cells transfected with MYD88 siRNA, there was a significant reduction in the fold induction of IL1B, IL6, and IL8 mRNA associated with LPS treatment (Fig. 2, F-H) .
Nontargeting siRNA (S) had no significant effect on TLR4 or MYD88 mRNA expression (Figs. 1, A and E, and 2, A and E) or the induction of IL1B, IL6, and IL8 mRNA expression associated with LPS treatment in either epithelial (Figs. 1, B-D, and 2 , B-D) or stromal cells (Figs. 1, F-H, and 2, F-H) .
Using the accumulation of IL6 as a marker of the inflammatory response of endometrial cells to LPS, transfection with TLR4 or MYD88 siRNA reduced the accumulation of IL6 in the supernatants of stromal cells treated with 1 lg/ml LPS for 48 h (Fig. 3) . Nontargeting siRNA (S) had no significant effect on IL6 accumulation (data not shown).
NFKB and MAPK Activation
Untreated endometrial stromal cells were monitored for more than 100 min with no evidence of IKB-EGFP degradation (Fig. 4Bi, green) or NFKB/p65-dsRed nuclear translocation (Fig. 4Bii, red) , but treatment with 1 lg/ml LPS resulted in degradation of IKB-EGFP (Fig. 4Di, blue arrows) and the subsequent translocation of p65-dsRed into the nucleus after ;40 min (Fig. 4Dii, white arrows) . However, not all LPStreated cells showed IKB-EGFP degradation or p65-dsRed nuclear translocation (Fig. 4D, lower cell) . Treatment of stromal cells with LPS induced phosphorylation of MAPK14 at Thr180 and Tyr182 between 5 and 25 min after treatment with LPS (Fig. 5) .
Biochemical Inhibition of NFKB and MAPK Signaling
Biochemical inhibition of MAPK3/1 reduced LPS induction of IL1B, IL6, and IL8 mRNA expression in epithelial cells (Fig.  6 , A-C) and in stromal cells (Fig. 6, D-F) . U0126 reduced LPS induction of IL1B and IL6. However, the effect of U0126 on LPS-induced IL8 mRNA expression in stromal cells (Fig. 6F ) and interleukin expression in epithelial cells (Fig. 6 , A-C) was highly variable. To address the role of other MAPKs, we also used MAPK14 and JNK biochemical inhibitors. Inhibition of MAPK14 did not significantly suppress cytokine mRNA expression in response to LPS (IL6, 1.1 6 0.3-fold and 0.3 6 0.2-fold change compared with LPS in epithelial cells and stromal cells, respectively; P . 0.05). Also, the inhibition of JNK did not significantly suppress cytokine mRNA expression 
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in response to LPS (IL1B, 3.1 6 0.8-fold and 1.8 6 0.7-fold change compared with LPS in epithelial cells and stromal cells, respectively; P . 0.05). The inhibition of NFKB resulted in reduced IL1B, IL6, and IL8 mRNA expression in both cell types; however, the inhibitor resulted in significantly reduced cell survival after 6 h.
Using the accumulation of IL6 protein as a marker of the inflammatory response of endometrial cells to 1 lg/ml LPS, the inhibition of MAPK3/1 also reduced the LPS-induced secretion of IL6 protein in the supernatants of epithelial cells after 6 and 24 h (Fig. 7A ) and stromal cells after 6 and 24 h (Fig. 7B) . Inhibition of MEK using U0126 reduced secretion of IL6 at 6 h in epithelial cells (Fig. 7A ) and 6 and 24 h in stromal cells (Fig.  7B) . Because inhibition of MEK was less effective than inhibition of downstream MAPK3/1 at 24 h, a second MEK inhibitor was used; however, PD98059 only reduced secretion of IL6 in epithelial or stromal cells after 6 h (Fig. 7, A and B) . Because MEK inhibition was effective at reducing LPSinduced IL6 secretion at 6 but not 24 h, the effect of the inhibition of MEK on LPS-induced MAPK3/1 phosphorylation at shorter time points was determined. Inhibition of MEK with PD98059 reduced the LPS-induced phosphorylation of MAPK3 and MAPK1 after 15 min (Fig. 8A, lane 5, and B ) and 30 min (Fig. 8A, lane 8, and B) in stromal cells.
DISCUSSION
The endometrium is a unique mucosa because it is normally sterile throughout pregnancy but becomes exposed to many bacteria during the postpartum period. Indeed, infections of the female genital tract with Gram-negative bacteria cause significant disease and even mortality in cattle [3, 8] . Specific endometrial pathogenic E. coli have been identified in bovine endometrium [34] . The impact of Gram-negative infections on tissues and the immune defense against these bacteria are highly dependent on recognition of their LPS by TLR4 [12, 13, 35] . Although the function of human and mouse TLR4 has been explored in the intact endometrium, less is known about its role in cattle [34, 36, 37] . So, the present study tested the hypothesis that TLR4-and MYD88-dependent signaling is essential for the response to LPS by the epithelial and stromal cells of the bovine endometrium. Although this hypothesis is particularly relevant to postpartum infections, other microbes contaminate the endometrium around the time of coitus, and so the present study also addresses the fundamental matter of whether epithelial or stromal cells have innate immune capabilities to initiate inflammatory responses to PAMPs. Indeed, treatment of primary bovine epithelial and stromal cells with LPS elicited proinflammatory cytokine and chemokine responses, which were prevented by siRNA targeting TLR4 or its associated adaptor MYD88. In addition, the NFKB and MAPK signaling pathways downstream of MYD88 were activated by LPS. However, only inhibition of MAPK3/1 consistently attenuated this inflammatory response.
The chemokine IL8 is central to the influx of neutrophils associated with uterine disease in cattle, and intrauterine infusion of IL8 mimics the disease in vivo [11] . Similarly, IL1B and IL6 are highly expressed in the endometrium of animals with uterine disease [10] . Treatment of endometrial cells with ultrapure LPS stimulated an inflammatory response characterized by increased IL1B, IL6, and IL8 mRNA expression, and IL6 protein accumulation in epithelial cells; and increased IL1B and IL8 mRNA expression, and IL6 and IL8 protein accumulation in stromal cells. Similarly, human endometrial epithelial cells challenged with LPS have previously been shown to secrete less IL8 compared with LPSchallenged human endometrial stromal cells [34] . Although IL6 and IL8 accumulated in the supernatants of the endometrial cells challenged with LPS in vitro, we were unable to detect mature IL1B protein by ELISA, perhaps because IL1B is expressed in a pro form, and its maturity is orchestrated by the inflammasome and the subsequent activation of caspase 1, which cleaves pro-IL1B [35] . Epithelial cells normally have a key role in sensing luminal bacteria in mucosa [36] . However, the loss of the epithelial layer postpartum exposes the stromal cells to the bacteria in the uterine lumen [9, 23] . Considering that stromal cells are much more abundant than epithelial cells in the endometrium and are in closer proximity to the vasculature and mononuclear cells, the stromal cells may have equal importance in the immune response to microbes in the endometrium. The importance of TLR4 and MYD88 for recognition of LPS was confirmed using siRNA. Knockdown of TLR4 or MYD88 reduced IL1B, IL6, and IL8 mRNA expression and IL6 protein accumulation in the supernatants of cells treated with LPS.
To further understand the mechanism responsible for TLR4/ MYD88 signaling, the activation of downstream NFKB and MAPK pathways was explored. In the absence of an activating signal, NFKB localizes in the cytosol as a result of a direct interaction with IKB [37] . The phosphorylation of IKB triggers its ubiquitination and degradation, which frees NFKB to translocate into the nucleus to drive gene expression [38] [39] [40] . In the present study, LPS activated the NFKB signaling cascade, resulting in the degradation of IKB and the translocation of p65 NFKB into the nucleus of stromal cells. Interestingly, not all stromal cells activated NFKB signaling in response to LPS treatment, which is in line with a recent report showing cells of identical genotype had diverse responses to the same stimulus, potentially allowing for extra levels of control in the innate immune response without cells having to undergo differentiation [41] .
As well as activating transcription factors, such as NFKB, TLR4/MYD88 signaling activates a number of kinases, including MEK, MAPK3/1, and MAPK14 [17] [18] [19] MAPK inhibition attenuated LPS-induced secretion of IL6 protein in endometrial cell supernatants. Epithelial (A) and stromal (B) cells isolated from bovine endometrium were cultured for 6 or 24 h in medium (control, C) or media containing 1 lg/ml LPS from E. coli 0111:B4. Inhibitors (ERK activation inhibitor peptide I, 10 lM; U0126, 10 lM; and PD98059, 10 lM) were added to the cells 30 min prior to and during LPS 6 inhibitor treatment. Supernatants were harvested to measure the accumulation of IL6 by ELISA. Data are presented as mean percentage þ SEM relative to LPS treatment and represent at least three independent experiments. The significance was evaluated by ANOVA with Dunnett postcomparison test comparing LPS to LPS plus inhibitor within the time period. *P , 0.05, **P , 0.01, ***P , 0.001.
TLR4 AND MYD88 SIGNALING IN BOVINE ENDOMETRIUM [42] . MAPK3/1 is activated by phosphorylation, and numerous studies have shown that LPS activates MAPK3/1 in macrophages (reviewed in Guha and Mackman [43] ). Here, stromal cells isolated from bovine endometrium phosphorylated MAPK3/1 after 5 min of treatment with LPS, and increased phosphorylation was evident for up to 20 min. Because LPS treatment resulted in phosphorylation of MAPK3/1, we used an ERK activation inhibitor peptide, which selectively binds to MAPK1 and prevents its interaction with MEK. Inhibition of MAPK3/1 reduced proinflammatory cytokine and chemokine gene expression in endometrial cells, indicating that MAPK3/1 signaling is an integral mechanism in the innate response of endometrial cells to LPS. Conversely, inhibition of MEK by U0126 or PD98059 was less effective than the MAPK3/1 inhibitor, despite MEK being upstream of MAPK3/1 in the cell signaling cascade. The MEK inhibitor, PD98059, was able to limit MAPK3/1 phosphorylation at 15 or 30 min, so MEK activation may be more important in acute LPS-induced signaling in endometrial epithelial and stromal cells than in prolonged LPS-induced signaling. MAPK signaling is known to be more complex than a linear activated pathway, and there is evidence for MEK-independent pathways regulating the prolonged activation of MAPK3/1 [44] .
Similarly, although we were able to show phosphorylation of MAPK14 approximately 5 min after treatment of stromal cells with LPS, the inhibition of MAPK14 also gave inconsistent results. Thus, small-molecule inhibitors of MAPK14 are unlikely to be good therapeutic targets for uterine disease. Interestingly, we were unable to detect TNF in the supernatants of LPS-treated epithelial and stroma cells. Because the stability of TNF mRNA depends on MAPK14, which acts by blocking AU-rich elements-directed deadenylation, inhibiting MAPK14 may be more important where there is a TNF response. Indeed, the absence of TNF in the present study reflects in vitro studies where TNF was not increased in animals with uterine disease [9] .
In conclusion, not only epithelial cells but also stromal cells have roles in the innate immune defense of the endometrium. The endometrial cells secrete cytokines and chemokines in response to the LPS of Gram-negative bacteria via TLR4/ MYD88-dependent pathways, and inhibition of MAPK3/1 countered the proinflammatory response. These insights into host immunity in the endometrium may focus the search for therapeutics that control inflammation associated with uterine disease.
